Skip to content

A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)

A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06207474
Enrollment
148
Registered
2024-01-17
Start date
2022-04-18
Completion date
2023-04-18
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Brief summary

This randomized trial explored whether digital media (videos and chatbots) used for patient education could more effectively reduce anxiety in breast cancer patients during radiation therapy, compared to traditional paper-based methods. Post-surgery breast cancer patients scheduled for radiation therapy were assigned to groups receiving treatment information through different media combinations. The study aimed to assess whether these modern tools more effectively ease anxiety, thus potentially improving patient compliance and treatment experience.

Detailed description

This study evaluates the impact of patient management and information provision using educational videos and chatbots on patient experience, satisfaction, and patient psychology in the breast cancer radiation treatment process. The experiment is designed as (2 (with or without using chatbot) X 2 (with or without using video) to distinguish groups. There is no separate treatment intervention in addition to use chatbot and video utilization.

Interventions

OTHERVideo + Chatbot

Participants will receive detailed information about the radiation therapy process, potential side effects, frequently asked questions, and aftercare instructions using a combination of educational videos and interactive chatbot sessions.

OTHERVideo + Paper

Participants will receive detailed information about the radiation therapy process, potential side effects, frequently asked questions, and aftercare instructions using a combination of educational videos and paper materials.

OTHERPaper + Chatbot

Participants will receive detailed information about the radiation therapy process, potential side effects, frequently asked questions, and aftercare instructions using a combination of paper materials and interactive chatbot sessions.

OTHERPaper + Paper

Participants will receive detailed information about the radiation therapy process, potential side effects, frequently asked questions, and aftercare instructions using paper materials.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

1. A breast cancer patient scheduled for radiation therapy after radical surgery. 2. Subjects must have the cognitive ability to use smartphone. 3. Age ≥ 20 year old

Exclusion criteria

1. Patients with visual or auditory impairment. 2. Subjects do not consent to participate in this study. 3. Pregnancy, fetus, newborn, underage 4. Age ≥ 75 year old

Design outcomes

Primary

MeasureTime frameDescription
APAIS(Amsterdam Preoperative Anxiety and Information Scale)baseline, before radiation therapy, after all radiation, an average of 1 monthThe Amsterdam Preoperative Anxiety and Information Scale (APAIS): The APAIS consists of six self-reported items, primarily assessing anxiety associated with anesthesia and surgery.

Secondary

MeasureTime frameDescription
STAI-X(State-Trait Anxiety Inventory for Adults)baseline, before radiation therapy, after all radiation, an average of 1 monthThe STAI is a widely recognized self-report instrument for gauging anxiety levels.
LASA(Linear Analog Scale Assessments)baseline, before radiation therapy, after all radiation, an average of 1 monthLASA is a tool to measure a patient's self-assessment of various aspects of their health and wellbeing.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026